1/8/25 16:50  | 1/6/25  | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turner Christopher Durant | MA | O | Chief Me | S.d | -320 | 79.68 | 0 | -4 | -6 | 63 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/6/23 16:58  | 10/4/23  | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turner Christopher Durant | MA | O | Chief Me | M.d | 55 | 6.89 | 0 | 8 | 123 | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/6/23 16:58  | 10/4/23  | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turner Christopher Durant | MA | O | Chief Me | S.d | -432 | 54.04 | 0 | -8 | -36 | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/28/23 16:51  | 7/26/23  | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turner Christopher Durant | MA | O | Chief Me | M.dm | 35 | 6.89 | 0 | 5 | 53 | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/28/23 16:51  | 7/26/23  | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turner Christopher Durant | MA | O | Chief Me | S.dm | -241 | 47.95 | 0 | -5 | -26 | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/24/23 16:54  | 7/20/23  | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turner Christopher Durant | MA | O | Chief Me | M.dm | 2 | 6.89 | 0 | 0 | 2 | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/24/23 16:54  | 7/20/23  | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turner Christopher Durant | MA | O | Chief Me | S.dm | -14 | 46.81 | 0 | 0 | -2 | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/7/23 16:50  | 6/5/23  | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turner Christopher Durant | MA | O | Chief Me | M.d | 71 | 6.89 | 0 | 10 | 239 | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/7/23 16:50  | 6/5/23  | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turner Christopher Durant | MA | O | Chief Me | S.d | -459 | 44.86 | 0 | -10 | -41 | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/19/22 16:36  | 5/17/22  | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Turner Christopher Durant | MA | O | Chief Me | M.d | 100 | 6.89 | 0 | 15 | New | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |